Triple agonist drug retatrutide shows 21% weight loss in patients with diabetes

Nearly one-quarter of participants with a baseline BMI of 35 or higher and type 2 diabetes, who took retatrutide 12 mg, lost an average of 61 lbs.…
Published: 1 October 2026